DHI

Analyst Consensus on DHI Stock Priced at $173.42

After this morning's 10.1% surge to $173.42 per share, D.R. Horton might just keep moving past its target price of $165.64. With an average analyst rating of buy, and target prices from $104.0 to $205.0, the stock's next move is anyone's guess.

The stock has an average amount of shares sold short at 2.6%, and a short ratio of 3.12. The company's insiders own 10.01% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 84.3% of D.R. Horton's shares being owned by this investor type.

Institutions Invested in D.R. Horton

Date Reported Holder Percentage Shares Value
2024-03-31 Vanguard Group Inc 11% 34,856,397 $6,044,796,303
2024-03-31 Blackrock Inc. 10% 33,073,674 $5,735,636,484
2024-03-31 Capital World Investors 4% 14,475,449 $2,510,332,339
2024-03-31 State Street Corporation 4% 13,481,448 $2,337,952,687
2024-03-31 JP Morgan Chase & Company 3% 11,480,024 $1,990,865,741
2024-03-31 Capital Research Global Investors 3% 11,298,293 $1,959,349,951
2024-03-31 Bank of America Corporation 3% 8,493,397 $1,472,924,892
2024-03-31 Geode Capital Management, LLC 2% 6,941,876 $1,203,860,123
2024-03-31 FMR, LLC 2% 5,477,636 $949,931,625
2024-03-31 Parnassus Investments, LLC 1% 4,424,810 $767,350,542

Besides an analyst consensus of little upside potential, other market factors point to there being positive market sentiment on D.R. Horton.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS